Radiolabelled peptides for oncological diagnosis

@inproceedings{Laverman2011RadiolabelledPF,
  title={Radiolabelled peptides for oncological diagnosis},
  author={Peter Laverman and Jane K. Sosabowski and Otto C Boerman and Wim J. G. Oyen},
  booktitle={European Journal of Nuclear Medicine and Molecular Imaging},
  year={2011}
}
Radiolabelled receptor-binding peptides targeting receptors (over)expressed on tumour cells are widely under investigation for tumour diagnosis and therapy. The concept of using radiolabelled receptor-binding peptides to target receptor-expressing tissues in vivo has stimulated a large body of research in nuclear medicine. The 111In-labelled somatostatin analogue octreotide (OctreoScan™) is the most successful radiopeptide for tumour imaging, and was the first to be approved for diagnostic use… CONTINUE READING
25 Citations
134 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 25 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 134 references

Are GRP-receptors present in the human pancreas

  • A Fröberg, M Visser, T Maina, J Erion, J de Swart, M de Jong
  • J Nucl Med
  • 2006
Highly Influential
17 Excerpts

Similar Papers

Loading similar papers…